Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
20 Décembre 2024 - 10:59PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the Schedule 13G (or any amendments thereto) relating to the Common Stock of Palvella Therapeutics, Inc. is filed on behalf of each of us.
Dated: December 20, 2024
Samsara BioCapital, L.P.
By:
Samsara BioCapital GP, LLC
its
General Partner
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
Samsara BioCapital GP, LLC
By:
/s/ Srinivas Akkaraju
Name: Srinivas Akkaraju
Title: Managing Member
/s/ Srinivas Akkaraju
Srinivas Akkaraju
Palvella Therapeutics (NASDAQ:PVLA)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Palvella Therapeutics (NASDAQ:PVLA)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025